Patents by Inventor Kevin Simon Eisenfrats

Kevin Simon Eisenfrats has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OCCLUSIVE IMPLANT COMPOSITIONS
    Publication number: 20240325593
    Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
    Type: Application
    Filed: December 29, 2023
    Publication date: October 3, 2024
    Inventors: John C. Herr, Alexander L. Klibanov, Kevin Simon Eisenfrats
  • Occlusive implant compositions
    Patent number: 11904068
    Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
    Type: Grant
    Filed: February 17, 2022
    Date of Patent: February 20, 2024
    Assignee: University of Virginia Patent Foundation
    Inventors: John C. Herr, Alexander L. Klibanov, Kevin Simon Eisenfrats
  • OCCLUSIVE IMPLANT COMPOSITIONS
    Publication number: 20220168461
    Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
    Type: Application
    Filed: February 17, 2022
    Publication date: June 2, 2022
    Inventors: John C. Herr., Alexander L. Klibanov, Kevin Simon Eisenfrats
  • Occlusive implant compositions
    Patent number: 11278641
    Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: March 22, 2022
    Assignee: University of Virginia Patent Foundation
    Inventors: John C. Herr, Alexander L. Klibanov, Kevin Simon Eisenfrats
  • METHODS FOR VAS-OCCLUSIVE CONTRACEPTION AND REVERSAL THEREOF
    Publication number: 20190060513
    Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
    Type: Application
    Filed: October 29, 2018
    Publication date: February 28, 2019
    Inventors: John C. Herr, Alexander L. Klibanov, Kevin Simon Eisenfrats
  • Methods for vas-occlusive contraception and reversal thereof
    Patent number: 10155063
    Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: December 18, 2018
    Assignee: University of Virginia Patent Foundation
    Inventors: John C. Herr, Alexander L. Klibanov, Kevin Simon Eisenfrats
  • METHODS FOR VAS-OCCLUSIVE CONTRACEPTION AND REVERSAL THEREOF
    Publication number: 20170136143
    Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
    Type: Application
    Filed: November 11, 2016
    Publication date: May 18, 2017
    Inventors: John C. Herr, Alexander L. Klibanov, Kevin Simon Eisenfrats
  • COMPOSITIONS AND METHODS FOR VAS-OCCLUSIVE CONTRACEPTION
    Publication number: 20170136144
    Abstract: Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.
    Type: Application
    Filed: November 11, 2016
    Publication date: May 18, 2017
    Inventors: John C. Herr, Alexander L. Klibanov, Kevin Simon Eisenfrats